Table 3 A - Low and High fasting urinary (U) MDA excretion, plasma (P) concentration of uric acid, ratio U-MDA/P-Uric acid; B-Ca saltcrystal nucleation and other data in postprandialurine; C - complementary data from fasting period

FASTING

POSTPRANDIAL

COMPLEMENTARY

Low ^x

T-Ox ^a

T-Ca ^b

T-Ca/

pH ^c

CaOx

HAP

FE-N-Alb-P

U-Volume

U-Na

Insulin

BMI

High ^xx

10 ² × T-Ox

mM/l

mM/l

ΔG

ΔG

% × 10 ³

ml

mM

μU/ml

kg/(m) ²

U-MDA; nM¹)

89(2);88

0.52(0.03);25 24(3);20

0.51(0.08);20

5.46(0.09);29 1.3(0.1);84

3.1(0.3);84

1.5(0.1);85

167(13);88

11(0.5);88

16(1);86

26.0(0.3);88

175(5);88

0.53(0.03);35 20(3);26

0.44(0.07);26

5.57(0.08);44 0.5(0.1);80

2.7(0.3);80

2.9(0.6);85

283(17);88

14(0.8);88

18(1);87

26.7(0.4);88

p

< 0.001

0.41^d

0.18^d

0.23^d

0.17

< 0.001

0.17

0.002^d

< 0.001

< 0.001

0.15

0.08

P-Uric acid;

301(10);94

0.54(0.03);30 16(2);25

0.34(0.06);25

5.72(0.10);36 0.8(0.1);88

3.5(0.3);88

2.9(0.6);91

252(17);94

13(0.6);94

14(1);93

25.4(0.3);94

μM -1^{-1 2})

425(10);93

0.52(0.02);33 27(3);24

0.59(0.08);24

5.35(0.07);43 1.0(0.1);84

2.1(0.3);84

1.5(0.1);90

197(14);93

12(0.7);93

18(1);91

27.2(0.3);93

p

< 0.001

0.29^d

0.007^d

0.007^d

0.001

0.18

0.001

< 0.008^d

0.007

0.03

0.003^d

< 0.001

U-MDA/P-Uric acid;

244(6);88

0.52(0.03);27 25(3);20

0.55(0.09);20

5.41(0.08);33 1.3(0.1);78

2.8(0.4);78

1.4(0.1);85

157(12);88

11(0.5);88

17(1);86

26.6(0.3);88

nM/mM -l^{-1 3)}

525(18);88

0.54(0.03);33 19(3);26

0.41(0.06);26

5.62(0.08);40 0.6(0.1);86

3.0(0.3);86

3.0(0.7);88

293(17);88

14(0.8);88

16(1);87

26.1(0.4);88

P

< 0.001

0.26^d

0.09^d

0.13^d

0.04

< 0.001

0.38

< 0.001^d

< 0.001

< 0.001

0.18

0.13